Kiran Arya

Bharat Parenterals Ltd

Bharat Parenterals Limited was formed under the chairmanship of Mr. Ramesh Desai and incorporated as Limited Company on 3rd September 1992. The company has grown steadily from a humble beginning, to a position of strength under the stewardship of Mr. Bharat R. Desai, a visionary. The company has a portfolio of over 800 products spread over more than 20 different therapeutical categories. Our WHO-GMP manufacturing unit is accredited further as a 2 Star Export House. We are the trusted partner of 60+ clients exporting to 15+ countries in semi-regulated & ROW markets. What differentiates us from the plethora of Indian contract manufacturing services providers is our DSIR Approved Formulation R&D Centre for Excellence that is constantly engaging in the development of optimized & innovative formulations. At our core manufacturing facility are 3 units each dedicated to the development of – General, Cephalosporin, and B-Lactam drug formulations. A publicly traded company on the BSE, in over 3 decades of its existence, the company driven with its core values & on an aggressive pursuit of organic growth now serves as parent company to 3 dynamic and growing organizations: Varenyam Healthcare Private Limited: The domestic marketing arm of Varenyam with a team of over 200 Medical Sales professions, marketing branded formulations in niche therapy area of anaesthesia & critical care. Varenyam Bio-Lifesciences: A progressive manufacturing unit dedicated to niche formulations such as PFS, emulsion injectables & other injectables, proposed to be accredited by EU- GMP and other semi-regulated region's bodies. Innoxel Lifesciences Limited: A first of its kind US FDA - manufacturing unit in India embarking upon a journey of pioneering advancement of Health with futuristic patient centric treatment solutions.